Cipla Ltd.

₹1,344

-2 (-0.1%)

CIPLA Share Price

Pharmaceuticals & Biotechnology

As on October 1, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,08,808 Cr

P/E Ratio27.99

Dividend Yield0.48 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,370.54	Bearish
10-DMA	1,379.94	Bearish
20-DMA	1,377.29	Bearish
50-DMA	1,415.19	Bearish
100-DMA	1,413.01	Bearish
200-DMA	1,380.8	Bearish

Historical Performance

1 Year

-11.2%

3 Years

13.3%

5 Years

36.3%

10 Years

131.7%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	2,81,626	2,75,476	2,57,741	2,27,531	2,17,633
Total Expenditure	2,22,797	2,04,248	1,94,830	1,77,628	1,72,514
Other Income	8,820	8,669	7,466	5,121	3,217
Operating Profit	67,649	79,898	70,376	55,024	48,337
Interest	544	620	899	1,095	1,063
Depreciation	12,110	11,069	10,510	11,721	10,519
Profit Before Tax	52,236	68,208	57,019	40,384	34,933
Consolidated Net Profit	38,792	52,725	41,215	28,019	25,168
Adjusted EPS	48	65	51	35	31

Compounded Sales Growth

10 Years:15.7

5 Years:8

3 Years:4.4

TTM:0.4

Compounded Profit Growth

10 Years:23.3

5 Years:10

3 Years:6.7

TTM:-6

Stock Price CAGR

10 Years:8.6

5 Years:6.4

3 Years:4.3

TTM:-11.5

Return on Equity

10 Years:12.5

5 Years:31.2

3 Years:51.1

last year:48

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	1,616	1,615	1,615	1,614	1,614
Total Reserves	3,42,079	3,09,178	2,64,584	2,31,845	2,06,363
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	611	-310	819	1,835	6,217
Other Current Liabilities	13,786	7,730	8,910	10,076	7,698
Short Term Borrowings	1,405	801	2,470	1,879	3,933
Total Liabilities	4,15,950	3,67,422	3,21,300	2,90,067	2,66,523
Capital Work in Progress	15,863	12,128	8,643	6,892	3,829
Long Term Loans & Advances	13,218	10,384	8,444	8,495	7,364
Currents Investments	76,794	72,932	48,070	30,899	21,950
Short Term Loans and Advances	23,676	34,814	31,342	25,632	15,071
Total Current Assets	2,41,459	2,32,490	1,93,924	1,68,051	1,47,108
Total Assets	4,15,950	3,67,422	3,21,300	2,90,067	2,66,523
Adjusted Book Value	425	385	330	289	258

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 27.99, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of 4.4%, indicating poor shareholder returns.
The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹67649 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹281626 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 885550.5

No. of Shares: 659 (Approx)

Performance:-11.4%

-114449.5

NIFTY Performance: -9.9%

1 day Top Gainers